Preeclampsia: A Marker for Future Cardiovascular Risk in Women



Status:Suspended
Conditions:High Blood Pressure (Hypertension), Women's Studies
Therapuetic Areas:Cardiology / Vascular Diseases, Reproductive
Healthy:No
Age Range:21 - 50
Updated:1/19/2019
Start Date:May 2012
End Date:July 2019

Use our guide to learn which trials are right for you!

This study will compare blood vessel and hormone differences between women who have a history
of a pregnancy complicated by preeclampsia or high blood pressure, and women who have a
history of uncomplicated pregnancy in the last 10 years. The investigators hypothesize that
postpartum women with history of preeclampsia will have altered blood vessel function and
abnormal hormone levels compared with postpartum women with history of uncomplicated
pregnancy.

This study will take place over the course of 2 weeks. Each subject will be assessed on a
fixed low-salt diet and a fixed high-salt diet. Subjects will have 2 non-invasive blood
vessel imaging tests and fasting blood draws.


Inclusion Criteria:

1. Healthy female premenopausal volunteers, with regular menstrual cycles (at least 8
cycles per year)

2. Age 21 to 50 years

3. Systolic blood pressure <140 and >90 mmHg and diastolic blood pressure <90 and >60
mmHg at the screening visit

4. Body mass index < 35 kg/m2

5. History of normotensive pregnancy or history of preeclamptic or hypertensive pregnancy
within the last 10 years

6. No clinically significant abnormalities on screening tests (complete blood count,
serum electrolytes, liver enzymes, thyroid stimulating hormone, urinalysis, and
electrocardiogram)

Exclusion Criteria:

1. Current pregnancy

2. Lactation

3. Elevated blood pressure (systolic blood pressure > 140 mmHg or diastolic blood
pressure > 90 mmHg)

4. Current diagnosis of hypertension

5. Current diagnosis of diabetes mellitus

6. Personal history of coronary disease, stroke and kidney disease

7. Use of prescription medications (with the exception of stable thyroid hormone
replacement dose) within 2 weeks of study

8. Use of oral contraceptives or other hormone therapy within 3 months of study;

9. Renal impairment (estimated GFR<60)

10. Active liver disease (AST, ALT, alkaline phosphatase > 1.5 times normal);

11. Current smoking, defined as smoking within the 6 months before the screening visit

12. Current or past recreational drug use
We found this trial at
1
site
75 Francis street
Boston, Massachusetts 02115
(617) 732-5500
Brigham and Women's Hosp Boston’s Brigham and Women’s Hospital (BWH) is an international leader in...
?
mi
from
Boston, MA
Click here to add this to my saved trials